about
Mechanism of Action of Bortezomib and the New Proteasome Inhibitors on Myeloma Cells and the Bone Microenvironment: Impact on Myeloma-Induced Alterations of Bone RemodelingThe Proteasome Inhibitor Bortezomib Maintains Osteocyte Viability in Multiple Myeloma Patients by Reducing Both Apoptosis and Autophagy: A New Function for Proteasome Inhibitors.Increased osteocyte death in multiple myeloma patients: role in myeloma-induced osteoclast formation.Bone marrow Dikkopf-1 levels are a new independent risk factor for progression in patients with smouldering myeloma.Cutaneous localization in multiple myeloma in the context of bortezomib-based treatment: how do myeloma cells escape from the bone marrow to the skin?A Rare Case of Systemic AL Amyloidosis with Muscle Involvement: A Misleading Diagnosis.Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells.Overexpression of HOXB7 and homeobox genes characterizes multiple myeloma patients lacking the major primary immunoglobulin heavy chain locus translocations
P50
Q28082335-B0B75BA2-F977-46B8-A4A3-8C0453265BECQ38820789-612C101E-7359-4166-BAC8-4BA9A57C455FQ44774590-5251624A-516F-4D7A-9FDE-DEE4275CD198Q48294981-344DEFB3-E423-404D-9C48-8A71407ED9D6Q48323207-3D7EF4A0-1EA2-4839-8DCF-1F51C5EAD1F0Q53693265-73A50EF5-E836-46BE-A7E2-61CAEC183815Q54301591-774A491B-E084-463A-ACC2-AB3849982E9EQ60197153-CF2FBA20-A9E0-42FF-B27F-0138C32E3788
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
B Dalla Palma
@en
B Dalla Palma
@nl
type
label
B Dalla Palma
@en
B Dalla Palma
@nl
prefLabel
B Dalla Palma
@en
B Dalla Palma
@nl
P31
P496
0000-0002-5198-3452